• 1
    Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 9196.
  • 2
    Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464470.
  • 3
    Axelrod DA, Guidinger MK, Finlayson S, Schaubel DE, Goodman DC, Chobanian M, et al. Rates of solid-organ wait-listing, transplantation, and survival among residents of rural and urban areas. JAMA 2008; 299: 202207.
  • 4
    Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ. Disparities in liver transplantation before and after introduction of the MELD score. JAMA 2008; 300: 23712378.
  • 5
    Tuttle-Newhall JE, Rutledge R, Johnson M, Fair J. A statewide, population-based, time series analysis of access to liver transplantation. Transplantation 1997; 63: 255262.
  • 6
    McCormick PA, O’Rourke M, Carey D, Laffoy M. Ability to pay and geographical proximity influence access to liver transplantation even in a system with universal access. Liver Transpl 2004; 10: 14221427.
  • 7
    Akaike H. A new look at the statistical model identification. IEEE Transactions on Automatic Control 1974; 19: 716723.
  • 8
    Kawachi I, Bekman LF. Neighborhood and Health . New York , NY : Press OU; 2003.
  • 9
    Freeman DH. Applied Categorical Data Analysis . New York , NY : Marcel Dekker, Inc; 1987.
  • 10
    Kleinbaum D, Kupper L, Muller K, Nizam A. Applied Regression Analysis and Other Multivariable Techniques . 4th Ed. Boston : PWS-Kent; 2007.
  • 11
    Cox DR, Oakes D. Analysis of Survival Data . New York , NY : Chapman and Hall; 1984.
  • 12
    Molinari M, Renfrew PD, Petrie NM, De Coutere S, Abdolell M. Clinical epidemiological analysis of the mortality rate of liver transplant candidates living in rural areas. Transpl Int 2011; 24: 292299.
  • 13
    Freeman RB, Jr. Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card. Hepatology 2008; 47: 10521057.
  • 14
    Fink MA, Berry SR, Gow PJ, Angus PW, Wang BZ, Muralidharan V, et al. Risk factors for liver transplantation waiting list mortality. J Gastroenterol Hepatol 2007; 22: 119124.
  • 15
    Silberhumer GR, Hetz H, Rasoul-Rockenschaub S, Peck-Radosavljevic M, Soliman T, Steininger R, et al. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival? Transpl Int 2006; 19: 275281.
  • 16
    Kemmer N, Zacharias V, Kaiser TE, Neff GW. Access to liver transplantation in the MELD era: role of ethnicity and insurance. Dig Dis Sci 2009; 54: 17941797.
  • 17
    Burr AT, Shah SA. Disparities in organ allocation and access to liver transplantation in the USA. Expert Rev Gastroenterol Hepatol 2010; 4: 133140.
  • 18
    Shannon G, Bashshur R, Metzner C. The concept of distance as a factor in accessibility and utilization of health care. Med Care Rev 1969; 26: 143161.
  • 19
    Greenberg ER, Dain B, Freeman D, Yates J, Korson R. Referral of lung cancer patients to university hospital cancer centers. A population-based study in two rural states. Cancer 1988; 62: 16471652.
  • 20
    Goodwin JS, Freeman JL, Freeman D, Nattinger AB. Geographic variations in breast cancer mortality: do higher rates imply elevated incidence or poorer survival? Am J Public Health. 1998; 88: 458460. PMCID: 1508360.
  • 21
    Goodwin JS, Freeman JL, Mahnken JD, Freeman DH, Nattinger AB. Geographic variations in breast cancer survival among older women: implications for quality of breast cancer care. J Gerontol A Biol Sci Med Sci 2002; 57: M401M406.
  • 22
    Davis AE, Ladner D, Skaro AI, Daskin MS, Mehrotra S, Daud A, et al. Geographic access of liver transplant patients to US transplant centers. Hepatology 2011; 52: 1239A.
  • 23
    Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864871.